CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 2, 2009--
Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live by Goldman Sachs on Tuesday, June 9,
2009 at 11:55 a.m. ET from the Grand Hyatt Hotel in New York City. In
addition, Alkermes’ corporate presentation will be webcast live by
Needham and Company on Wednesday, June 10, 2009 at 9:30 a.m. ET from the
New York Palace Hotel in New York City. The presentations may be
accessed under the investor relations tab at www.alkermes.com.
The presentations will be archived for 14 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to
developing innovative medicines to improve patients' lives. Alkermes
developed, manufactures and commercializes VIVITROL® for
alcohol dependence and manufactures RISPERDAL® CONSTA®
for schizophrenia and bipolar disorder. Alkermes' robust pipeline
includes extended-release injectable, pulmonary and oral products for
the treatment of prevalent, chronic diseases, such as central nervous
system disorders, addiction and diabetes. Headquartered in Cambridge,
Massachusetts, Alkermes has research facilities in Massachusetts and a
commercial manufacturing facility in Ohio.
Source: Alkermes, Inc.
Alkermes, Inc.
Eva Stroynowski, 617-583-6823
Corporate
Communications
